✨
AI Summary
- Big pharma executive pay, US vaccine panel changes, and Merck's RSV approval.
- Discussion on MFN and Japan, and the Pfizer/Arvinas partnership.
- Scrip's weekly biopharma industry news roundup for June 13, 2025.